Abstract:Background This study aimed to investigate the impact of intrauterine adhesions (IUA) therapy and endometrial receptivity by implanting autologous bone marrow mesenchymal stem cells (BMSCs) into the Interceed and subsequently placing them in the uterine cavity of rats. Methods Fifty rats were divided into 5 groups according to the random number table method (10 rats in each group). Following the development of the IUA model through mechanical injury, the animals were categorized into different treatment groups: the IUA model (intrauterine perfusion of saline), Interceed therapy (intrauterine placement of Interceed), BMSCs therapy (intrauterine perfusion of BMSCs), BMSCs + Interceed therapy (intrauterine placement of BMSCs + Interceed), and a control group (intrauterine perfusion of saline). The Hematoxylin-eosin (HE) staining technique was employed to identify and assess the pathological alterations in the endometrium. Additionally, it facilitated the quantification of endometrial glands and the determination of endometrial thickness. Masson staining was used to detect fibrosis in rat uterus. The number of microvascular density (MVD) was detected by immunohistochemistry (IHC). Real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR) and Western blot were used to detect the levels of leukemia inhibitory factor (LIF), integrin ανβ3, and vascular endothelial growth factor (VEGF) in uterine tissue. Male and female rats were combined in cages for reproductive and conception evaluation. Results In comparison to the control, the number of endometrial glands in the IUA model was significantly reduced, and the degree of endometrial thinning and fibrosis was significantly increased ( p < 0.05). Compared with the IUA model, the number of endometrial glands did not exhibit any significant alterations in endometrial thickness and MVD number. The expressions of LIF, integrin ανβ3, and VEGF in the uterine tissue were not significantly improved with Interceed therapy, resulting in no significant improvement in the pregnancy rate ( p > 0.05). The number of endometrial glands, endometrial thickness, and MVD in the BMSCs therapy group were significantly increased. Moreover, the expressions of LIF, integrin ανβ3, and VEGF in uterine tissue exhibited a significant increase, leading to a comparatively higher pregnancy rate ( p < 0.05). In the BMSCs + Interceed therapy group, the number of endometrial glands, endometrial thickness, and MVD were significantly increased, and the expressions of LIF, integrin ανβ3, and VEGF in uterine tissue were significantly increased as well, along with a corresponding rise in the pregnancy rate ( p < 0.05). Conclusion The intrauterine placement of Interceed combined with BMSCs in IUA rats can thicken the damaged endometrium, increase the number of glands, promote endometrial angiogenesis, improve endometrial receptivity, and increase the rate of pregnancy in IUA rats.

Organoid Transplantation Can Improve Reproductive Prognosis by Promoting Endometrial Repair in Mice

Therapeutic Effect of Human Amniotic Epithelial Cells in Rat Models of Intrauterine Adhesions

Endometrial Stem Cells Repair Injured Endometrium and Induce Angiogenesis Via AKT and ERK Pathways.

Transplantation Induced Pluripotent Stem Cells In Situ Improves Fertility Outcome Impaired By Intrauterine Adhesions In Mice

An Acellular Scaffold Facilitates Endometrial Regeneration and Fertility Restoration Via Recruiting Endogenous Mesenchymal Stem Cells

The development of uterine adenomyosis induced by pituitary isografting in female ICR mice

In Situ Delivery of Apoptotic Bodies Derived from Mesenchymal Stem Cells Via a Hyaluronic Acid Hydrogel: A Therapy for Intrauterine Adhesions.

Platelet-rich plasma improves therapeutic effects of menstrual blood-derived stromal cells in rat model of intrauterine adhesion

Recent Trends in Therapeutic Strategies for Repairing Endometrial Tissue in Intrauterine Adhesion

Incorporation of Decidual Stromal Cells Derived Exosomes in Sodium Alginate Hydrogel as an Innovative Therapeutic Strategy for Advancing Endometrial Regeneration and Reinstating Fertility

Endometrial organoids: a reservoir of functional mitochondria for uterine repair

Transplantation of acellularized amniotic membrane seeded with adipose-derived mesenchymal stem cells in a rat model of intrauterine adhesion

Human Endometrial Mesenchymal Stem Cells Restore Ovarian Function Through Improving the Renewal of Germline Stem Cells in a Mouse Model of Premature Ovarian Failure

Effective Therapy of Endometrial Injury by Slow-Releasing Human Placenta-Derived Mesenchymal Stem Cells Encapsulated Within Hyaluronic Acid Hydrogels

Human amnion mesenchymal stem cells promote endometrial repair via paracrine, preferentially than transdifferentiation

Regeneration of Injured Endometrium Using Acellularized Amniotic Membrane Loaded with Adipose- Derived Mesenchymal Stem Cells in a Rat Model

Advanced Biomaterials for Promoting Endometrial Regeneration

Transplantation of human endometrial perivascular stem cells with hydroxy saffron yellow A promotes uterine repair in rats

Transplantation of Menstrual Blood-Derived Mesenchymal Stem Cells (mbmscs) Promotes the Regeneration of Mechanical Injuried Endometrium.

Restoration of functional endometrium in an intrauterine adhesion rat model with endometrial stromal cells transplantation

Interceed combined with bone marrow mesenchymal stem cells improves endometrial receptivity of intrauterine adhesion